Page last updated: 2024-08-24

capecitabine and Neoplasms, Squamous Cell

capecitabine has been researched along with Neoplasms, Squamous Cell in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Birzgalis, A; Homer, J; Jegannathen, A; Lee, L; Mais, K; Ryder, WD; Slevin, N; Sykes, A; Yap, B	1
Blasiak, J; Bloch, K; Chojnacki, J; Drzewoski, J; Kaczmarczyk, D; Kasznicki, J; Krupa, R; Morawiec-Sztandera, A; Sliwinski, T; Wisniewska-Jarosinska, M	1
Ahmed, RL; Dudek, A; Endrizzi, B; Lee, P; Ray, T	1

Trials

1 trial(s) available for capecitabine and Neoplasms, Squamous Cell

Article	Year
Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study. Clinical oncology (Royal College of Radiologists (Great Britain)), 2011, Volume: 23, Issue:2 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome	2011

Article

Year

Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2011, Volume: 23, Issue:2

Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome

2011

Other Studies

2 other study(ies) available for capecitabine and Neoplasms, Squamous Cell

Article	Year
Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells. Molecular biology reports, 2011, Volume: 38, Issue:6 Topics: Capecitabine; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Comet Assay; Deoxycytidine; DNA Damage; DNA Repair; DNA Repair Enzymes; DNA, Circular; Drug Screening Assays, Antitumor; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphocytes; Mutagens; Neoplasms, Squamous Cell; Plasmids; Spin Labels; Time Factors	2011
Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Child; Child, Preschool; Deoxycytidine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Male; Neoplasms, Squamous Cell; Organ Transplantation; Skin Neoplasms; Tumor Burden; Young Adult	2013

Article

Year

Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells.

Molecular biology reports, 2011, Volume: 38, Issue:6

Topics: Capecitabine; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Comet Assay; Deoxycytidine; DNA Damage; DNA Repair; DNA Repair Enzymes; DNA, Circular; Drug Screening Assays, Antitumor; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphocytes; Mutagens; Neoplasms, Squamous Cell; Plasmids; Spin Labels; Time Factors

2011

Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:4

Topics: Administration, Oral; Adolescent; Adult; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Child; Child, Preschool; Deoxycytidine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Male; Neoplasms, Squamous Cell; Organ Transplantation; Skin Neoplasms; Tumor Burden; Young Adult

2013